This typically involves reducing dose frequency (weekly injections become every 10 days, then every 2 weeks) before stopping entirely, paired with behavioral intensification
(12) M Macvanin, Z Gluvic, J Radovanovic, M Essack, et al (2023) New insights on the cardiovascular effects of IGF-1 Frontiers in Endocrinology (Lausanne), 2023 Feb 9, Volume 14, Page 1142644
Pre-Blend Vials (15 mg: 12.5 mg reta + 2.5 mg cag) One vial covers about 6-10 weekly doses depending on where you are in titration
Compositionally it is the GLOW three-peptide blend with KPV added, which is where the K in the name comes from
Patients were excluded if they did not have at least two months of GLP-1 RA prescription fills